BIOMAT Database Logo BIOMAT Database Logo

[Development of the low molecular weight heparin fraction CY 216 in the prevention of postoperative thrombosis in general surgery]. 1988

F Toulemonde

UI MeSH Term Description Entries
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

F Toulemonde
Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
January 1993, International surgery,
F Toulemonde
[Efficacy and tolerance of the low molecular weight heparin fraction CY 216 in preventing postoperative venous thromboembolism].
October 1986, Medizinische Klinik (Munich, Germany : 1983). Supplement,
F Toulemonde
The disappearance of a low molecular weight heparin fraction (CY 216) differs from standard heparin in rabbits.
June 1987, Thrombosis research,
F Toulemonde
Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis.
January 1992, Nephron,
F Toulemonde
[Recent data on the mechanism of action of the low molecular weight heparin fraction CY 216].
October 1986, Medizinische Klinik (Munich, Germany : 1983). Supplement,
F Toulemonde
Pharmacological studies on the low molecular weight heparin derivative CY 216.
July 1990, Die Pharmazie,
F Toulemonde
Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery.
June 1992, Thrombosis and haemostasis,
F Toulemonde
Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.
November 1986, Thrombosis research,
F Toulemonde
[Prevention of thrombosis in surgery: low molecular weight heparin/standard heparin].
January 1990, Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress,
F Toulemonde
Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis.
February 1988, The British journal of surgery,
Copied contents to your clipboard!